22223702

Don? G

2012

Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome.

22226490

Kim JW

2012

Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome.

22229564

Diamanti-Kandarakis E

2012

Phenotypes and enviromental factors: their influence in PCOS.

22230306

Sweet MG

2012

Evaluation and management of abnormal uterine bleeding in premenopausal women.

22233423

Lerchbaum E

2012

Adult-type hypolactasia and calcium intake in polycystic ovary syndrome.

22234472

Saller S

2012

Norepinephrine, active norepinephrine transporter, and norepinephrine-metabolism are involved in the generation of reactive oxygen species in human ovarian granulosa cells.

22235508

Navali N

2011

Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial.

22236023

Franconi F

2012

Sex-gender differences in diabetes vascular complications and treatment.

22237020

Li Y

2012

Polymorphism T?C of gene CYP17 promoter and polycystic ovary syndrome risk: a meta-analysis.

22238112

Nelson SM

2012

Anti-M?llerian hormone: clairvoyance or crystal clear?

22238371

Chua AK

2012

Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.

22238403

Gonzalez D

2012

Loss of WT1 expression in the endometrium of infertile PCOS patients: a hyperandrogenic effect?

22239938

Xian L

2012

ADIPOQ gene polymorphisms and susceptibility to polycystic ovary syndrome: a HuGE survey and meta-analysis.

22243998

Pimentel AM

2012

Transvaginal ultrasound ovarian diathermy: sheep as an experimental model.

22245531

Veiga-Lopez A

2012

Developmental programming: prenatal testosterone excess disrupts anti-M?llerian hormone expression in preantral and antral follicles.

22245830

Bellanger S

2012

Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells.

22246378

Hutchison SK

2012

Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome.

22248781

Witek J

2011

[Insulin resistance in children].

22248822

Verdin H

2012

FOXL2 impairment in human disease.

22249553

Lopes IM

2011

Endometrium in women with polycystic ovary syndrome during the window of implantation.

22252083

Bairagi S

2012

Glucose-induced increase in circulating progenitor cells is blunted in polycystic amenorrhoeic subjects.

22253351

Lalwani N

2012

Miscellaneous tumour-like lesions of the ovary: cross-sectional imaging review.

22256938

Boyle JA

2012

Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia.

22258336

Shibata H

2012

Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.

22260889

Eleftheriadou M

2012

Exercise and sedentary habits among adolescents with PCOS.

22260890

Bechtold S

2012

Effect of antiandrogen treatment on bone density and bone geometry in adolescents with polycystic ovary syndrome.

22260937

Muscogiuri G

2012

Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?

22261835

Yamamoto M

2012

Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome.

22262974

Gateva A

2012

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity.

22263397

Kasum M

2011

New insights in prediction of ovarian hyperstimulation syndrome.

22264851

Mokhlesi B

2012

Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.

22265003

Dos Santos E

2012

Adiponectin and leptin systems in human endometrium during window of implantation.

22265923

Legro RS

2012

The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

22268285

Demir B

2011

Morphologic and functional vascular alterations in patients with polycystic ovary syndrome.

22270277

Carmina E

2012

A 20-year follow-up of young women with polycystic ovary syndrome.

22270301

Sung JF

2012

Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome.

22270872

Jia H

2012

Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis.

22273414

Jones GL

2011

Health-related quality of life among adolescents with polycystic ovary syndrome.

22275470

Restuccia DF

2012

Loss of PKB?/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo.

22275473

Lerchbaum E

2012

Vitamin D and fertility: a systematic review.

22276997

Zhai HL

2012

Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats.

22277163

Maliqueo M

2012

Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women.

22279474

Mardanian F

2011

Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome.

22281885

Christakou C

2011

Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander?

22286793

Szymanska M

2011

Gestational diabetes in IVF and spontaneous pregnancies.

22286802

Lewandowski KC

2011

Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.

22287962

Wongwananuruk T

2012

Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome.

22288821

Altieri P

2013

Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome.

22289262

Ma C

2012

Trans-abdominal ultrasound guided transvaginal hydrolaparoscopy is associated with reduced complication rate.

22291712

Rahmani E

2012

Dosage optimization for letrozole treatment in clomiphene-resistant patients with polycystic ovary syndrome: a prospective interventional study.

22294071

Pimenta E

2012

Renal Sympathetic Denervation for Treatment of Hypertension.

22295823

Zhang CR

2012

[Thirty cases of PCOS treated by the according to stage moxibustion on medicinal cake and acupuncture].

22296306

Unfer V

2012

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.

22296324

Nectaria X

2012

The importance of ER? and ER? gene polymorphisms in PCOS.

22296403

Liu B

2012

Common variants of transcription factor 7-like 2 (TCF7L2) are associated with reduced insulin secretion in women with polycystic ovary syndrome.

22296561

K???? N

2012

Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.

22299621

Bremer AA

2012

Insulin resistance in pediatric disease.

22300604

Garc?a-Mayor RV

2012

[Endocrine disruptors and obesity: obesogens].

22301903

Yalamanchi SK

2012

Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS.

22301914

Wang Y

2012

Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women.

22304663

Aydogdu A

2012

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.

22304834

Haviland JA

2012

Novel diagnostics of metabolic dysfunction detected in breath and plasma by selective isotope-assisted labeling.

22306327

Mart?nez-Garc?a MA

2012

The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.

22308849

Savas Erdeve S

2011

Characteristics and prevalence of non-classical congenital adrenal hyperplasia with a V2811 mutation in patients with premature pubarche.

22309514

Li W

2012

Insulin resistance but not impaired ?-cell function: a key feature in Chinese normal-weight PCOS women with normal glucose regulation.

22309615

Akbarzadeh S

2012

Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI.

22309675

Curi DD

2012

Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.

22309801

Bu Z

2012

The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level.

22309835

Atis A

2012

Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries.

22311022

Knebel B

2012

Genetic variations in SREBP-1 and LXR? are not directly associated to PCOS but contribute to the physiological specifics of the syndrome.

22313145

G?d?c? N

2012

Serum visfatin levels in women with polycystic ovary syndrome.

22313155

Di Carlo C

2012

Case report: a most peculiar family with spontaneous, recurrent ovarian hyperstimulation syndrome.

22314079

Zhang Z

2012

Plasma level of calcitonin gene-related peptide in patients with polycystic ovary syndrome and its relationship to hormonal and metabolic parameters.

22314456

Anwary SA

2012

Outcome of metformin treatment in polycystic ovary syndrome.

22316276

Deveer R

2012

Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome.

22322053

Li GH

2011

[Clinical characteristics and perinatal outcomes of non-overweight/obese pregnant women with polycystic ovary syndrome].

22324645

Karjane NW

2012

Persistence with oral contraceptive pills versus metformin in women with polycystic ovary syndrome.

22327820

Gonz?lez F

2013

Elevated circulating levels of tissue factor in polycystic ovary syndrome.

22328164

Luna SL

2012

In vivo ?-adrenergic blockade by propranolol prevents isoproterenol-induced polycystic ovary in adult rats.

22329744

Celik C

2012

Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?

22329763

Maier PS

2012

17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.

22330149

Ott J

2012

Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study.

22333283

Yan X

2011

[Pregnancy outcomes of patients with polycystic ovary syndrome undergoing in vitro fertilization and embryo transfer].

22334228

Le Donne M

2012

[Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].

22334715

van Houten EL

2012

Reproductive and metabolic phenotype of a mouse model of PCOS.

22334855

Mahde A

2009

Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients.

22335316

Bode D

2012

Hirsutism in women.

22336088

Arya BK

2012

Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism.

22336524

Castell AL

2012

[Post-menopausal ovarian hyperthecosis].

22337333

Walters KA

2012

Rodent models for human polycystic ovary syndrome.

22337865

Feng Y

2012

Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5?-dihydrotestosterone-induced rat polycystic ovary syndrome model.

22338097

Palomba S

2012

The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome.

22340740

Chao KC

2012

Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women.

22341880

Harlow SD

2012

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

22341881

Sopher AB

2012

Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition.

22342814

Nair S

2012

Increased COMT expression in PCOS biology.

22343019

Zhang D

2012

Functions of water channels in male and female reproductive systems.

22343706

Sanch?n R

2012

Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.

22344199

Chazenbalk G

2012

Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.

22344533

Xia Y

2012

Polymorphic CAG repeat in the androgen receptor gene in polycystic ovary syndrome patients.